Rafael Ochoa‐Sanchez

1.3k total citations · 1 hit paper
22 papers, 993 citations indexed

About

Rafael Ochoa‐Sanchez is a scholar working on Endocrine and Autonomic Systems, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rafael Ochoa‐Sanchez has authored 22 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrine and Autonomic Systems, 9 papers in Cognitive Neuroscience and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rafael Ochoa‐Sanchez's work include Circadian rhythm and melatonin (10 papers), Sleep and Wakefulness Research (8 papers) and Liver Disease and Transplantation (5 papers). Rafael Ochoa‐Sanchez is often cited by papers focused on Circadian rhythm and melatonin (10 papers), Sleep and Wakefulness Research (8 papers) and Liver Disease and Transplantation (5 papers). Rafael Ochoa‐Sanchez collaborates with scholars based in Canada, Italy and United States. Rafael Ochoa‐Sanchez's co-authors include Gabriella Gobbi, Stefano Comai, Christopher F. Rose, Luca Posa, Danilo De Gregorio, Ryan J. McLaughlin, Sabatino Maione, Justine P. Enns, Martha López-Canul and Francis Rodriguez Bambico and has published in prestigious journals such as Journal of Neuroscience, Pain and Small.

In The Last Decade

Rafael Ochoa‐Sanchez

22 papers receiving 979 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

2018 276 citations Danilo De Gregorio, Ryan J. McLaughlin et al. Pain profile →

Peers

Rafael Ochoa‐Sanchez

EAS

CMN

PHARM

PHYSI

Ida Fredriksson United States

Martha López-Canul Canada

Steven P. Vickers United Kingdom

Manoj P. Dandekar India

Sergio Melotto Italy

Anna Brancato Italy

Caroline A. Browne United States

David V. Gauvin United States

Michelle Baladi United States

Salar Vaseghi Iran

Ida Fredriksson United States

Rafael Ochoa‐Sanchez

162 ×0.5

EAS

565 ×2.0

CMN

154 ×0.6

201 ×0.8

PHARM

205 ×1.2

PHYSI

Citations per year, relative to Rafael Ochoa‐Sanchez Rafael Ochoa‐Sanchez (= 1×) peers Ida Fredriksson

Countries citing papers authored by Rafael Ochoa‐Sanchez

Since Specialization

Citations

This map shows the geographic impact of Rafael Ochoa‐Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Ochoa‐Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Ochoa‐Sanchez more than expected).

Fields of papers citing papers by Rafael Ochoa‐Sanchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Ochoa‐Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Ochoa‐Sanchez. The network helps show where Rafael Ochoa‐Sanchez may publish in the future.

Co-authorship network of co-authors of Rafael Ochoa‐Sanchez

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Ochoa‐Sanchez. A scholar is included among the top collaborators of Rafael Ochoa‐Sanchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Ochoa‐Sanchez. Rafael Ochoa‐Sanchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López-Canul, Martha, Danilo De Gregorio, Rafael Ochoa‐Sanchez, et al.. (2024). Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT₁Receptors Located in the Locus Ceruleus Norepinephrine Neurons. Journal of Neuroscience. 44(29). e0914232024–e0914232024. 5 indexed citations

Ochoa‐Sanchez, Rafael, et al.. (2023). Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats. JHEP Reports. 5(12). 100904–100904. 11 indexed citations

Ochoa‐Sanchez, Rafael, et al.. (2021). Hepatic Encephalopathy: From Metabolic to Neurodegenerative. Neurochemical Research. 46(10). 2612–2625. 24 indexed citations

Comai, Stefano, Danilo De Gregorio, Luca Posa, et al.. (2020). Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT₂ receptors. Journal of Pineal Research. 69(1). e12653–e12653. 26 indexed citations

Matoori, Simon, Yinyin Bao, Rafael Ochoa‐Sanchez, et al.. (2019). An Investigation of PS‐ b ‐PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia. Small. 15(50). e1902347–e1902347. 28 indexed citations

Aamann, Luise, Rafael Ochoa‐Sanchez, Mélanie Tremblay, et al.. (2018). Progressive resistance training prevents loss of muscle mass and strength in bile duct‐ligated rats. Liver International. 39(4). 676–683. 13 indexed citations

Ochoa‐Sanchez, Rafael & Christopher F. Rose. (2018). Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease. Journal of Clinical and Experimental Hepatology. 8(3). 262–271. 58 indexed citations

Gregorio, Danilo De, Ryan J. McLaughlin, Luca Posa, et al.. (2018). Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. 160(1). 136–150. 276 indexed citations breakdown →

Comai, Stefano, Luca Posa, Rafael Ochoa‐Sanchez, Gilberto Spadoni, & Gabriella Gobbi. (2017). Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands. European Neuropsychopharmacology. 27. S569–S569. 4 indexed citations

10.

Gregorio, Danilo De, Luca Posa, Rafael Ochoa‐Sanchez, et al.. (2016). The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors. Pharmacological Research. 113(Pt A). 81–91. 81 indexed citations

11.

Bosoi, Cristina R., Rafael Ochoa‐Sanchez, Mélanie Tremblay, et al.. (2016). The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis. Metabolic Brain Disease. 32(2). 513–518. 30 indexed citations

12.

Comai, Stefano, Rafael Ochoa‐Sanchez, Sergio Domínguez-López, Francis Rodriguez Bambico, & Gabriella Gobbi. (2015). Melancholic-Like Behaviors and Circadian Neurobiological Abnormalities in Melatonin MT1 Receptor Knockout Mice. The International Journal of Neuropsychopharmacology. 18(3). pyu075–pyu075. 64 indexed citations

13.

Ochoa‐Sanchez, Rafael, Stefano Comai, Gilberto Spadoni, et al.. (2014). Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states. Neuroscience Letters. 561. 156–161. 29 indexed citations

14.

Comai, Stefano, Rafael Ochoa‐Sanchez, & Gabriella Gobbi. (2014). P.1.g.109 Distinct role of melatonin MT1 and MT2 receptors in sleep and anxiety: insights from melatonin receptor knockout mice. European Neuropsychopharmacology. 24. S268–S268. 1 indexed citations

15.

Comai, Stefano, Rafael Ochoa‐Sanchez, & Gabriella Gobbi. (2013). Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice. Behavioural Brain Research. 243. 231–238. 91 indexed citations

16.

Laplante, François, et al.. (2012). Reduction in cholinergic interneuron density in the nucleus accumbens attenuates local extracellular dopamine release in response to stress or amphetamine. Synapse. 67(1). 21–29. 11 indexed citations

17.

Ochoa‐Sanchez, Rafael, Quentin Rainer, Stefano Comai, et al.. (2012). Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 39(2). 318–325. 57 indexed citations

18.

Ochoa‐Sanchez, Rafael, Stefano Comai, Baptiste Lacoste, et al.. (2011). Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT₂Melatonin Receptor Ligand. Journal of Neuroscience. 31(50). 18439–18452. 106 indexed citations

19.

Labonté, Benoît, Ryan J. McLaughlin, Sergio Domínguez-López, et al.. (2011). Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood. The International Journal of Neuropsychopharmacology. 15(9). 1319–1330. 26 indexed citations

20.

Domínguez-López, Sergio, Ian Mahar, Francis Rodriguez Bambico, et al.. (2011). Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light–dark cycle. Journal of Psychopharmacology. 26(6). 830–844. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact